Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blepharoptosis in myasthenia gravis.

S Castronuovo, G B Krohel, R W Kristan

    Annals of Ophthalmology
    |August 1, 1983
    PubMed
    Summary

    Systemic myasthenia gravis (MG) with blepharoptosis shows favorable prognosis with multimodal therapy. Corrective lid surgery is a viable option for patients with stable, disabling ptosis after 3-4 years.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Active ocular syphilis.

    Ophthalmology·2001
    Same author

    Acute multifocal placoid pigment epitheliopathy and central nervous system involvement: nine new cases and a review of the literature.

    Ophthalmology·2001
    Same author

    Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy.

    Ophthalmology·2000
    Same author

    Aspirin use and the prevention of acute ischemic cranial nerve palsy.

    American journal of ophthalmology·2000
    Same author

    The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)

    Ophthalmology·1998
    Same author

    Recurrent herpes labialis as a potential risk factor for nonarteritic anterior ischemic optic neuropathy.

    Journal of the National Medical Association·1996

    Area of Science:

    • Ophthalmology
    • Neurology

    Background:

    • Blepharoptosis is a common manifestation of systemic myasthenia gravis.
    • Management of ocular symptoms in myasthenia gravis can be challenging.

    Purpose of the Study:

    • To evaluate the prognosis and surgical candidacy for blepharoptosis in patients with systemic myasthenia gravis.

    Main Methods:

    • Retrospective review of 23 patients with systemic myasthenia gravis and blepharoptosis.
    • Analysis of treatment outcomes including anticholinesterase medication and corrective lid surgery.

    Main Results:

    • Overall favorable prognosis for blepharoptosis improvement with multimodal therapy.
    • Four of five patients with disabling blepharoptosis achieved stability for corrective surgery after 3-4 years.
    • Two patients undergoing levator resection experienced good surgical outcomes.

    Conclusions:

    • Multimodal therapy, including anticholinesterase medications, improves blepharoptosis in myasthenia gravis.
    • Ptosis surgery is a recommended option for patients with stable, refractory blepharoptosis after a 3-4 year disease course.

    Related Experiment Videos